Lauren Bailey, MD
Emergency Medicine · Albuquerque, NMNPI 1295197556
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Ironshore Pharmaceuticals Inc. at 32.1% of the total. 2025 is the largest year on record at $96, 8.2 times the $12 reported in 2022. Among emergency medicine clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 12 payments — averaging $19.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$73
- Kowa Pharmaceuticals America, Inc.$41
- Boston Scientific$38
- Inari Medical, Inc.$30
- Johnson & Johnson$18
- Collegium Pharmaceutical, Inc.$16
- plus $12 from 1 others
What the payments were for
- Food & beverage$228100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 4 | $73 |
| Kowa Pharmaceuticals America, Inc. | 2 | $41 |
| Boston Scientific | 2 | $38 |
| Inari Medical, Inc. | 1 | $30 |
| Johnson & Johnson | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| CSL Behring | 1 | $12 |
How this compares
$228 in reported general payments places this provider in the 90th percentile of 367 emergency medicine providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 65 | $501 |
| Ondansetron OdtOndansetron | 62 | $346 |
| Cefdinir | 33 | $296 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $185 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $154 |
| Ciprofloxacin Hcl | 27 | $120 |
| Oxycodone Hcl | 38 | $92 |
| Metronidazole | 14 | $81 |
| Prednisone | 54 | $77 |
| Methylprednisolone | 15 | $77 |
| Tramadol Hcl | 13 | $27 |
| Clonidine Hcl | 14 | $24 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Albuquerque
- Jonathan MarinaroAlbuquerque$8K
- Julie KanterAlbuquerque$8K
- James CottonAlbuquerque$7K
- Ethan SimsAlbuquerque$4K
- Robert AlundayAlbuquerque$4K
- David SklarAlbuquerque$3K
- Tammy Baillio JonesAlbuquerque$1K
- Jessica MitchellAlbuquerque$565
- Wilson ChiuAlbuquerque$541
- Joseph RomeroAlbuquerque$433
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.